Related Experiment Video
Updated: Jun 3, 2025

07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
Non-small cell lung cancer in ever-smokers vs never-smokers
Jeremy R Burt1,2, Naim Qaqish3, Greg Stoddard4
1Department of Radiology, Cardiothoracic Imaging, University of Utah, Spencer Fox Eccles School of Medicine, 50 N Medical Dr, Salt Lake City, UT, 84132, USA. radhopkins@hsc.utah.edu.
BMC Medicine
|January 5, 2025
Summary
Non-smokers (NS) with non-small cell lung cancer (NSCLC) had similar early survival to ever-smokers (S). However, ever-smokers experienced nearly double the mortality risk within 5 and 10 years.
Area of Science:
- Oncology
- Pulmonology
- Epidemiology
Background:
- Lung cancer is a leading cause of cancer mortality.
- Non-small cell lung cancer (NSCLC) incidence is rising in never-smokers (NS).
- This study compares NSCLC in never-smokers (NS) versus ever-smokers (S).
Purpose of the Study:
- To compare clinical, imaging, pathology, and outcomes between NS and S NSCLC patients.
- To identify significant differences in NSCLC presentation and prognosis based on smoking history.
Main Methods:
- Retrospective cohort study of 155 NSCLC patients (67 NS, 88 S).
- Evaluated clinical, imaging, and pathology findings at initial biopsy for staging.
- Primary outcome: all-cause mortality; Secondary outcome: 12-month progression-free survival.
Main Results:
- Imaging features (nodule size, calcification, invasion) were similar between NS and S.
- NS patients more frequently presented with extrathoracic metastases and stage IV disease.
- NS patients more commonly had adenocarcinoma histology compared to S patients.
Conclusions:
- CT nodule features were similar in never-smokers (NS) and ever-smokers (S) with NSCLC.
- NS patients were more often diagnosed with metastatic adenopathy and stage IV disease.
- Ever-smokers (S) faced nearly double the mortality risk at 5 and 10 years post-diagnosis, despite similar early survival rates.
More Related Videos
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
299
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
299
Lung Capacity
49.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
49.3K

